유리체 절제 기기 시장 : 점유율 분석, 업계 동향과 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the vitrectomy devices market size in 2026 is estimated at USD 1.9 billion, growing from 2025 value of USD 1.8 billion with 2031 projections showing USD 2.51 billion, growing at 5.72% CAGR over 2026-2031.

This report is Segmented by Product Type (Vitrectomy System, Vitrectomy Packs, Photocoagulation Lasers, Instruments, and Other Product Types), Application (Diabetic Retinopathy, Retinal Detachment, Macular Hole, and More), End-Users (Hospitals, Ophthalmology Clinics, and Ambulatory Surgical Centers), and Geography (North America, Europe and More). The Market Forecasts are Provided in Terms of Value (USD).

Global Vitrectomy Devices Market Trends and Insights

Rising Global Burden of Vitreoretinal Disorders Drives Surgical Demand

Diabetic retinopathy affects nearly 10 million Americans and more than 100 million people worldwide, pushing continuous demand for surgical intervention. Proliferative disease often requires pars plana vitrectomy, as confirmed by a 10-year Indian cohort study highlighting the procedure's role in vision preservation. Age-related macular degeneration cases could reach 67 million in the European Union and 26 million in China, adding further load on surgical capacity. Cataract complications also create downstream vitrectomy need, maintaining baseline procedure volume.

Aging Population Demographics Reshape Surgical Volume Patterns

By 2025, adults aged 65 and older outnumber youth in the WHO European Region, underlining the demographic pivot toward older cohorts. The United Nations projects that one in six people globally will be over 60 by 2030, with 80% living in low and middle-income countries by 2050. This demographic reality compels healthcare systems to invest in vitreoretinal surgical capacity and advanced device technologies to serve an increasingly elderly patient population requiring complex interventions.

High Capital Investment Requirements Limit Market Penetration

Comprehensive equipment packages for two operating rooms can cost up to USD 1 million, an outlay that strains hospital budgets in emerging economies. The cost-effectiveness analysis of vitrectomy procedures shows favorable outcomes, with pars plana vitrectomy costing EUR 1,468.26 while delivering 6.84 lifetime quality-adjusted life years. Although lifetime cost-effectiveness analyses favour vitrectomy in terms of quality-adjusted life years, the initial capital barrier remains significant for many healthcare facilities, particularly those serving underserved populations where vitreoretinal expertise is most needed.

Other drivers and restraints analyzed in the detailed report include:

1. Advances in Minimally-invasive Vitrectomy Technologies
2. Ambulatory Surgical Centres Expand Market Access
3. Skilled Surgeon Shortage Constrains Market Growth

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Vitrectomy packs delivered 30.85% of the vitrectomy devices market share in 2025, reflecting their role as consumables for every case. Vitrectomy systems are projected to grow at a 6.95% CAGR, lifting their slice of the vitrectomy devices market size through 2031 as hospitals replace ageing consoles with integrated imaging and hypersonic technologies. Packs benefit from stable procedure counts and preference for manufacturer-matched consumables, giving suppliers predictable recurring revenue.

Instruments and photocoagulation lasers post mid-single digit gains, supported by stricter infection-control rules that favour single-use tools. FDA clearance of integrated platforms such as Alcon's Unity VCS underscores the shift toward multifunctional consoles that combine cutting, illumination, and laser features within one footprint.

Complete Report Scope:

• By Product Type
  • Vitrectomy Systems
  • Vitrectomy Packs
  • Photocoagulation Lasers
  • Instruments
  • Other Product Types
• By Application
  • Diabetic Retinopathy
  • Retinal Detachment
  • Macular Hole
  • Vitreous Hemorrhage
  • Other Applications
• By End-User
  • Hospitals
  • Ophthalmology Clinics
  • Ambulatory Surgical Centers
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America anchors 37.75% of the vitrectomy devices market in 2025, driven by 2.2 million annual procedures, strong reimbursement, and early adoption of hypersonic cutters. Workforce shortages loom, yet policy adjustments that widen scope of practice for optometrists and allied personnel may protect throughput. The FDA's decision to reclassify selected ultrasound devices from Class III to Class II has lowered market entry hurdles for component innovations. Canada pursues similar risk-based pathways, sustaining device inflows, while Mexico's Seguro Popular reforms are widening access to public ophthalmic care.

Asia-Pacific is forecast to post an 7.62% CAGR through 2031, buoyed by rapid demographic ageing and expanding middle-class insurance cover. Japan exemplifies clinical sophistication, operating with more than 114 ophthalmologists per million residents, whereas Indonesia and parts of South Asia still grapple with shortages. China's central procurement policies are pressuring average selling prices, yet procedure growth is offsetting margin compression for global suppliers. India's tier-2 cities welcome freestanding retina centres that adopt affordable 25-gauge consoles sourced under concessional import schemes.

Europe records steady mid-single digit growth thanks to universal health coverage and ageing demographics. Harmonised Medical Device Regulation simplifies simultaneous multi-country approvals, though post-market surveillance duties raise compliance costs that smaller entrants may struggle to meet. Germany and France lead regional demand, while the United Kingdom carves a separate approval route via the UKCA mark, extending timelines for dual submissions. Environmental mandates are encouraging adoption of reusable handpieces and regulated reprocessing to lower surgical waste, influencing future product design choices.

1. Alcon
2. Bausch + Lomb (Bausch Health)
3. Johnson & Johnson
4. Carl Zeiss Meditec AG (DORC)
5. GEUDER
6. BVI Medical
7. NIDEK Co. Ltd.
8. HOYA
9. Topcon Corp.
10. Danaher
11. Oertli Instrumente AG
12. Optikon 2000 SpA
13. MedOne Surgical
14. MANI, INC.
15. Oculus Surgical
16. Inami & Co.
17. Rumex International
18. Peregrine Surgical

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Rising Global Burden of Vitreoretinal Disorders (DR, RRD, AMD)
  • 4.2.2 Aging Population Boosting Surgical Volume Across Developed and Emerging Regions
  • 4.2.3 Advances in Minimally-invasive Vitrectomy Technologies
  • 4.2.4 Increased Awareness and Early Diagnosis
  • 4.2.5 Expansion of Ambulatory Surgical Centers & Favorable Outpatient Reimbursement for Retina
  • 4.2.6 Shift Toward Single-use Ophthalmic Instruments Driven by Strict Infection-control Mandates
• 4.3 Market Restraints
  • 4.3.1 High Capital & Maintenance Cost of Systems
  • 4.3.2 Post-operative Complications & Patient Anxiety
  • 4.3.3 Limited Availability of Skilled Vitreoretinal Surgeons in Developing Countries and Supply-chain Vulnerability for Precision Components
  • 4.3.4 Lengthy and Stringent Regulatory Approval Cycles
• 4.4 Regulatory Landscape
• 4.5 Technological Outlook
• 4.6 Porter's Five Forces Analysis
  • 4.6.1 Threat of New Entrants
  • 4.6.2 Bargaining Power of Buyers
  • 4.6.3 Bargaining Power of Suppliers
  • 4.6.4 Threat of Substitutes
  • 4.6.5 Competitive Rivalry

5 Market Size & Growth Forecasts (Value)

• 5.1 By Product Type
  • 5.1.1 Vitrectomy Systems
  • 5.1.2 Vitrectomy Packs
  • 5.1.3 Photocoagulation Lasers
  • 5.1.4 Instruments
  • 5.1.5 Other Product Types
• 5.2 By Application
  • 5.2.1 Diabetic Retinopathy
  • 5.2.2 Retinal Detachment
  • 5.2.3 Macular Hole
  • 5.2.4 Vitreous Hemorrhage
  • 5.2.5 Other Applications
• 5.3 By End-User
  • 5.3.1 Hospitals
  • 5.3.2 Ophthalmology Clinics
  • 5.3.3 Ambulatory Surgical Centers
• 5.4 By Geography
  • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
  • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
  • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest of Asia-Pacific
  • 5.4.4 Middle East and Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle East and Africa
  • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
  • 6.3.1 Alcon
  • 6.3.2 Bausch + Lomb (Bausch Health)
  • 6.3.3 Johnson & Johnson Vision
  • 6.3.4 Carl Zeiss Meditec AG (DORC)
  • 6.3.5 Geuder AG
  • 6.3.6 BVI
  • 6.3.7 NIDEK Co. Ltd.
  • 6.3.8 Hoya Surgical Optics
  • 6.3.9 Topcon Corp.
  • 6.3.10 Leica Microsystems
  • 6.3.11 Oertli Instrumente AG
  • 6.3.12 Optikon 2000 SpA
  • 6.3.13 MedOne Surgical
  • 6.3.14 MANI, INC.
  • 6.3.15 Oculus Surgical
  • 6.3.16 Inami & Co.
  • 6.3.17 Rumex International
  • 6.3.18 Peregrine Surgical

7 Market Opportunities & Future Outlook

• 7.1 White-space & Unmet-Need Assessment